Agios Reports Business Highlights and Third Quarter 2021 Financial Results

Go back to Agios Reports Business Highlights and Third Quarter 2021 Financial Results

Agios Pharma (AGIO) Tops Q3 EPS by 3c; Reports Cash and Cash Equivalents of $1.4B

November 3, 2021 7:17 AM EDT

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.56), $0.03 better than the analyst estimate of ($1.59).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

... More